Global Type 2 Diabetes market size is predicted to grow from US$ 81440 million in 2025 to US$ 137170 million in 2031; it is expected to grow at a CAGR of 9.1% from 2025 to 2031. Get access now!

Global Type 2 Diabetes Market Trends and Opportunities 2025-31

The global Type 2 Diabetes market size is predicted to grow from US$ 81440 million in 2025 to US$ 137170 million in 2031; it is expected to grow at a CAGR of 9.1% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors. According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Infinity Market Research newest research report, the Type 2 Diabetes Industry Forecast looks at past sales and reviews total world Type 2 Diabetes sales in 2024, providing a comprehensive analysis by region and market sector of projected Type 2 Diabetes sales for 2025 through 2031. With Type 2 Diabetes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Type 2 Diabetes industry. This Insight Report provides a comprehensive analysis of the global Type 2 Diabetes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Type 2 Diabetes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Type 2 Diabetes market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Type 2 Diabetes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Type 2 Diabetes. This report presents a comprehensive overview, market shares, and growth opportunities of Type 2 Diabetes market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Insulins &nbsp;&nbsp;&nbsp; DPP-4 Inhibitors &nbsp;&nbsp;&nbsp; GLP-1 Receptor Agonists &nbsp;&nbsp;&nbsp; SGLT-2 Inhibitors Segmentation by Application: &nbsp;&nbsp;&nbsp; Drugstore &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Novo Nordisk &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Eli Lily &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; Astellas Pharma &nbsp;&nbsp;&nbsp; Daiichi Sankyo &nbsp;&nbsp;&nbsp; Biocon &nbsp;&nbsp;&nbsp; Boehringer Ingelheim Key Questions Addressed in this Report What is the 10-year outlook for the global Type 2 Diabetes market? What factors are driving Type 2 Diabetes market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Type 2 Diabetes market opportunities vary by end market size? How does Type 2 Diabetes break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Type 2 Diabetes Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Type 2 Diabetes by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Type 2 Diabetes by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Type 2 Diabetes Segment by Type &nbsp;2.2.1 Insulins &nbsp;2.2.2 DPP-4 Inhibitors &nbsp;2.2.3 GLP-1 Receptor Agonists &nbsp;2.2.4 SGLT-2 Inhibitors &nbsp;2.3 Type 2 Diabetes Sales by Type &nbsp;2.3.1 Global Type 2 Diabetes Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Type 2 Diabetes Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Type 2 Diabetes Sale Price by Type (2020-2025) &nbsp;2.4 Type 2 Diabetes Segment by Application &nbsp;2.4.1 Drugstore &nbsp;2.4.2 Hospital &nbsp;2.4.3 Others &nbsp;2.5 Type 2 Diabetes Sales by Application &nbsp;2.5.1 Global Type 2 Diabetes Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Type 2 Diabetes Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Type 2 Diabetes Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Type 2 Diabetes Breakdown Data by Company &nbsp;3.1.1 Global Type 2 Diabetes Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Type 2 Diabetes Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Type 2 Diabetes Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Type 2 Diabetes Revenue by Company (2020-2025) &nbsp;3.2.2 Global Type 2 Diabetes Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Type 2 Diabetes Sale Price by Company &nbsp;3.4 Key Manufacturers Type 2 Diabetes Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Type 2 Diabetes Product Location Distribution &nbsp;3.4.2 Players Type 2 Diabetes Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Type 2 Diabetes by Geographic Region &nbsp;4.1 World Historic Type 2 Diabetes Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Type 2 Diabetes Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Type 2 Diabetes Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Type 2 Diabetes Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Type 2 Diabetes Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Type 2 Diabetes Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Type 2 Diabetes Sales Growth &nbsp;4.4 APAC Type 2 Diabetes Sales Growth &nbsp;4.5 Europe Type 2 Diabetes Sales Growth &nbsp;4.6 Middle East & Africa Type 2 Diabetes Sales Growth 5 Americas &nbsp;5.1 Americas Type 2 Diabetes Sales by Country &nbsp;5.1.1 Americas Type 2 Diabetes Sales by Country (2020-2025) &nbsp;5.1.2 Americas Type 2 Diabetes Revenue by Country (2020-2025) &nbsp;5.2 Americas Type 2 Diabetes Sales by Type (2020-2025) &nbsp;5.3 Americas Type 2 Diabetes Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Type 2 Diabetes Sales by Region &nbsp;6.1.1 APAC Type 2 Diabetes Sales by Region (2020-2025) &nbsp;6.1.2 APAC Type 2 Diabetes Revenue by Region (2020-2025) &nbsp;6.2 APAC Type 2 Diabetes Sales by Type (2020-2025) &nbsp;6.3 APAC Type 2 Diabetes Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Type 2 Diabetes by Country &nbsp;7.1.1 Europe Type 2 Diabetes Sales by Country (2020-2025) &nbsp;7.1.2 Europe Type 2 Diabetes Revenue by Country (2020-2025) &nbsp;7.2 Europe Type 2 Diabetes Sales by Type (2020-2025) &nbsp;7.3 Europe Type 2 Diabetes Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Type 2 Diabetes by Country &nbsp;8.1.1 Middle East & Africa Type 2 Diabetes Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Type 2 Diabetes Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Type 2 Diabetes Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Type 2 Diabetes Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Type 2 Diabetes &nbsp;10.3 Manufacturing Process Analysis of Type 2 Diabetes &nbsp;10.4 Industry Chain Structure of Type 2 Diabetes 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Type 2 Diabetes Distributors &nbsp;11.3 Type 2 Diabetes Customer 12 World Forecast Review for Type 2 Diabetes by Geographic Region &nbsp;12.1 Global Type 2 Diabetes Market Size Forecast by Region &nbsp;12.1.1 Global Type 2 Diabetes Forecast by Region (2026-2031) &nbsp;12.1.2 Global Type 2 Diabetes Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Type 2 Diabetes Forecast by Type (2026-2031) &nbsp;12.7 Global Type 2 Diabetes Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Novo Nordisk &nbsp;13.1.1 Novo Nordisk Company Information &nbsp;13.1.2 Novo Nordisk Type 2 Diabetes Product Portfolios and Specifications &nbsp;13.1.3 Novo Nordisk Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Novo Nordisk Main Business Overview &nbsp;13.1.5 Novo Nordisk Latest Developments &nbsp;13.2 Sanofi &nbsp;13.2.1 Sanofi Company Information &nbsp;13.2.2 Sanofi Type 2 Diabetes Product Portfolios and Specifications &nbsp;13.2.3 Sanofi Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Sanofi Main Business Overview &nbsp;13.2.5 Sanofi Latest Developments &nbsp;13.3 Merck &nbsp;13.3.1 Merck Company Information &nbsp;13.3.2 Merck Type 2 Diabetes Product Portfolios and Specifications &nbsp;13.3.3 Merck Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Merck Main Business Overview &nbsp;13.3.5 Merck Latest Developments &nbsp;13.4 Eli Lily &nbsp;13.4.1 Eli Lily Company Information &nbsp;13.4.2 Eli Lily Type 2 Diabetes Product Portfolios and Specifications &nbsp;13.4.3 Eli Lily Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Eli Lily Main Business Overview &nbsp;13.4.5 Eli Lily Latest Developments &nbsp;13.5 AstraZeneca &nbsp;13.5.1 AstraZeneca Company Information &nbsp;13.5.2 AstraZeneca Type 2 Diabetes Product Portfolios and Specifications &nbsp;13.5.3 AstraZeneca Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 AstraZeneca Main Business Overview &nbsp;13.5.5 AstraZeneca Latest Developments &nbsp;13.6 Astellas Pharma &nbsp;13.6.1 Astellas Pharma Company Information &nbsp;13.6.2 Astellas Pharma Type 2 Diabetes Product Portfolios and Specifications &nbsp;13.6.3 Astellas Pharma Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Astellas Pharma Main Business Overview &nbsp;13.6.5 Astellas Pharma Latest Developments &nbsp;13.7 Daiichi Sankyo &nbsp;13.7.1 Daiichi Sankyo Company Information &nbsp;13.7.2 Daiichi Sankyo Type 2 Diabetes Product Portfolios and Specifications &nbsp;13.7.3 Daiichi Sankyo Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Daiichi Sankyo Main Business Overview &nbsp;13.7.5 Daiichi Sankyo Latest Developments &nbsp;13.8 Biocon &nbsp;13.8.1 Biocon Company Information &nbsp;13.8.2 Biocon Type 2 Diabetes Product Portfolios and Specifications &nbsp;13.8.3 Biocon Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Biocon Main Business Overview &nbsp;13.8.5 Biocon Latest Developments &nbsp;13.9 Boehringer Ingelheim &nbsp;13.9.1 Boehringer Ingelheim Company Information &nbsp;13.9.2 Boehringer Ingelheim Type 2 Diabetes Product Portfolios and Specifications &nbsp;13.9.3 Boehringer Ingelheim Type 2 Diabetes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Boehringer Ingelheim Main Business Overview &nbsp;13.9.5 Boehringer Ingelheim Latest Developments 14 Research Findings and Conclusion

Report	Global Type 2 Diabetes Market Growth 2025-2031
Selected License	Single ID:LPI20867

Buyer Information

Order Summary